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Localization of Matrix Metalloproteinase MMP-2
to the Surface of Invasive Cells
by Interaction with Integrin avb3
Peter C. Brooks,* Staffan StroÈ mblad,* Recent studies have implicated the expression of the
Luraynne C. Sanders,* Tami L. von Schalscha,* vitronectin receptor integrin avb3 and the matrix metal-
Ronald T. Aimes,² William G. Stetler-Stevenson,³ loproteinase MMP-2 with invasive processes such as
James P. Quigley,² and David A. Cheresh* tumor cell metastasis and angiogenesis (Rucklidge et
*Departments of Immunology and Vascular Biology al., 1994; Grevin et al., 1993; Chen et al., 1991; Brooks
The Scripps Research Institute et al., 1994b). In fact, we have recently shown that func-
IMM24 10666 North Torrey Pines Road tional expression of integrin avb3 in CS-1 melanoma
La Jolla, California 92037 cells promotes spontaneous metastasis in vivo, whereas
²Department of Pathology control CS-1 cells have little if any metastatic ability
State University of New York at Stony Brook (Filardo et al., 1995). Moreover, the process of angiogen-
Stony Brook, New York 11794 esis, which involves the invasion of vascular endothelial
³National Cancer Institute Laboratory of Pathology cells, has also been shown to depend on integrin avb3
National Institutes of Health (Brooks et al., 1994a, 1994b, 1995). However, the molec-
Bethesda, Maryland 20892 ular mechanisms regulating cellular invasion are not well
understood. In fact, extensive uncontrolled extracellular
matrix degradation could impede the invasive process,
Summary since cells require specific matrix components for mi-
gration and survival (Ruoslahti, 1992; Montgomery et
Cellular invasiondepends on cooperation between ad- al., 1994). Therefore, a mechanism to coordinate cell
hesive and proteolytic mechanisms. Evidence is pro- adhesion and migration and the localization of proteo-
vided that the matrix metalloproteinase MMP-2 can lytic activity to discrete regions of the cell surface may
be localized in a proteolytically active form on the facilitate controlled proteolysis, resulting in directed cel-
surface of invasive cells, based on its ability to bind lular invasion. To this end, recent reports demonstrate
directly integrin avb3. MMP-2 and avb3 were specifi- cell surface localization of proteinases, including uroki-
cally colocalizedon angiogenic blood vessels andmel- nase type plasminogen activator (uPA) and MMP-2, on
anoma cells in vivo. Expression of avb3 on cultured a variety of cells both in vitro and in vivo (Emonard et
melanoma cells enabled their binding to MMP-2 in a al., 1992; Blasi, 1993). In fact, biochemical characteriza-
proteolytically active form, facilitating cell-mediated tion of cell-surface receptors for uPA have been re-
collagen degradation. In vitro, these proteins formed
ported (Blasi, 1993). Moreover, studies indicate that
anSDS-stable complex thatdepended on thenoncata- MMP-2 may require cell surface localization to potenti-
lytic C-terminus of MMP-2, since a truncation mutant
ate proteolytic activation (Murphy et al., 1992; Ward etlost the ability to bind avb3. These findings define a
al., 1991; Strongin et al., 1993). However, the mechanismsingle cell-surface receptor that regulates both matrix
by which MMP-2 is localized to the cell surface is notdegradation and motility, thereby facilitating directed
clear.cellular invasion.
In this report, we provide evidence that integrin avb3
localizes with MMP-2 in a functionally active form on
the cell surface.We demonstrate that MMP-2 associatesIntroduction
with avb3 on the surface of angiogenic blood vessels
and melanoma tumors in vivo. Significantly, MMP-2 wasCellular invasion depends on adhesion as well as pro-
found to bind directly integrin avb3, an interaction thatteolytic modification of the extracellular matrix. These
depends on the C-terminus of MMP-2 and thus localizescellular events contribute tomany normal and pathologi-
this enzyme in a proteolytically active form on the cellcal processes, such as trophoblast implantation, wound
surface. These findings provide a molecular basis tohealing, tumor cell invasion, and angiogenesis (Liotta et
explain how a single cell-surface receptor can regulateal., 1991; Montgomery et al., 1993; Pepper et al., 1994;
both cell migration and matrix degradation, thereby fa-Birkedal±Hansen, 1995). While cellular invasion depends
cilitating invasion.on adhesion, migration, and proteolytic activity (Lester
and McCarthy, 1992; Blood and Zetter, 1990), little is
Resultsknown about how these events are coordinated.
Matrix metalloproteinases are a family of zinc requir-
Integrin avb3 Colocalizes with MMP-2ing matrix-degrading enzymes, which include the colla-
on Angiogenic Blood Vessels In Vivogenases, gelatinases, and the stromelysins, all of which
Cellular invasion during tissue remodeling and morpho-have been implicated in invasive cell behavior (Stetler±
genesis depends on cell adhesion, migration, and pro-Stevenson et al., 1993; Kleiner and Stetler±Stevenson,
teolytic mechanisms. For example,during angiogenesis,1993; Hynes, 1992; Ruoslahti and Giancotti, 1989). The
avb3 expression is increased on the invasive endothe-integrin family of adhesion molecules are extracellular
lium (Brooks et al., 1994a). In fact, antagonists of avb3matrix receptorscomposed of noncovalently associated
block angiogenesis in various animal models (Brooks eta and b chains that form various heterodimers with dis-
al., 1994a, 1994b, 1995). However, angiogenesis cantinct cellular and adhesive specificities (Hynes, 1992).
also be abrogated with inhibitors of matrix metallopro-These receptors mediate both cell adhesion and migra-
tion in vitro (Hynes, 1992). teinases, suggesting that both avb3 and MMPs play a
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Figure 1. Integrin avb3 and MMP-2 Colocalize on Angiogenic Blood Vessels
Basic fibroblast growth factor±stimulated CAMs from 13-day-old chick embryos and avb3-negative human melanoma tumors (M21-L) grown
in human skin were resected and snap-frozen in liquid nitrogen. Cryostat sections (4 mm) were costained with both MAb LM609 directed to
integrin avb3 and polyclonal antibodies directed to MMP-2.
(A) Basic fibroblast growth factor±stimulated chick embryo angiogenic blood vessels. Arrows indicate quiescent blood vessels lacking
expression of integrin avb3.
(B) Human angiogenic blood vessels associated with a human melanoma tumor. Red indicates expression of integrin avb3, green indicates
expression of MMP-2, and yellow indicates colocalization of integrin avb3 and MMP-2. Bar indicates 25 mm.
critical role in this process (Moses et al., 1990; Moses severe combined immunodeficient mice. Tumors were
propagated for 3 weeks, at which time they becameand Langer, 1991). Therefore, we examined the localiza-
tion of avb3 and the metalloproteinase MMP-2 on endo- highly vascularized with human blood vessels, as pre-
viously described (Brooks et al., 1994b). Once again,thelial cells undergoing angiogenesis. Basic fibroblast
growth factor was used to induce angiogenesis on the avb3 and MMP-2 were colocalized on the angiogenic
tumor-associated blood vessels (Figure 1B). Minimalchorioallantoic membranes (CAM) of 10-day-old chick
embryos. The CAMs were resected and cryostat sec- staining of avb3 or MMP-2 was detected in association
with pre-existing nontumor-associated blood vesselstions were immunologically stained for the presence of
avb3 and MMP-2, 3 days later. As shown in Figure 1A, (data not shown). Together, these findings suggest that
integrin avb3 and MMP-2 associate on the same vascu-avb3 was highly expressed on angiogenic vessels, as
previously described (Brooks et al., 1994a). Interest- lar sprouts during cytokine-induced angiogenesis on the
chick CAM or tumor-induced angiogenesis within theingly, MMP-2 was observed to colocalize with avb3 on
the angiogenic vessels that expressed avb3 integrin but microenvironment of human skin.
was only minimally expressed on vessels that lacked
this receptor (Figure 1, arrows).
Expression of avb3 on Melanoma Cells PromotesAngiogenesis is associated with the growth of all solid
Colocalization with MMP-2 In Vivotumors. To determine whether avb3 and MMP-2 were
In addition to angiogenic vascular cells, certain invasivealso colocalized on tumor-associated blood vessels,
tumors express integrin avb3. In particular, human verti-avb3-negative M21-L human melanoma cells were in-
jected into the dermis of human skin grafts grown on cally invasive primary and metastatic melanomas have
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Figure 2. Expression of MMP-2 in CS-1 Melanoma Tumors In Vivo
Control CS-1 melanoma cells or CS-1 cells transfected with cDNAs encoding either b3 (b3CS-1) or b5 (b5CS-1) integrin subunit were inoculated
on the CAMs of 10-day-old chick embryos. Tumors were allowed to grow for 7 days, then resected and snap-frozen in liquid nitrogen.
(A) Cryostat sections (4 mm) from CS-1 tumor variants stained with a polyclonal antibody directed to MMP-2. Immunofluoresence was detected
with an Olympus BX60 epifluoresence microscope at 400 3.
(B) A single cryostat section from a b3CS-1 melanoma tumor was dual-stained with both MAb LM609 directed to integrin avb3 and polyclonal
anti±MMP-2 antibody. Fluoresence was detected with a Zeiss-laser confocal microscope at 400 3 (200 nm Z-section). Red indicates expression
of integrin avb3, and green indicates expression of MMP-2. Yellow indicates colocalization.
been shown to express avb3 preferentially, compared those transfected with cDNAs encoding either b3 or b5
integrin subunits were implanted on the CAMs of 10-with noninvasive primary melanomas (Albelda et al.,
1990). To evaluate a possible interaction between day-old chick embryos. As shown in Figure 2A, avb3-
bearing tumors showed extensive staining with anti±MMP-2 and avb3 on melanoma cells, we examined CS-
1 melanoma cells that failed to express either integrin MMP-2 (Figure 2, left panel). In contrast, tumors derived
from CS-1 cells lacking integrin avb3 or those express-avb3 or avb5 owing to the lack of b3 or b5 protein
(Thomas et al., 1993; Filardo et al., 1995). CS-1 cells or ing avb5 showed little, if any, detectable tumor cell±
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associated MMP-2, even though MMP-2 was readily
detected within the stroma of all tumors examined (mid-
dle and right panels). The surface-associated MMP-2
present on b3CS-1 tumorsshowed extensive colocaliza-
tion with integrin avb3, as measured by confocal analy-
sis (Figure 2B). These observations suggest that MMP-2
selectively associates with avb3-bearing melanoma
cells in vivo.
Interestingly, while avb3 was detected both within
and on the surface of these b3CS-1 tumor cells,
MMP-2 appeared to associate exclusively with the cell
surface of avb3-bearing cells, since it was not detected
within the cytoplasm of these cells as measured by con-
focal analysis (Figure 2B). This is likely due to the failure
of these cells to produce significant quantities of endog-
enous MMP-2 (Thomas et al., 1993). These observations
suggest that the increased association of MMP-2 on
avb3-bearing cells is due to the ability of these proteins
to interact on the cell surface and that the source of
MMP-2 present on these tumors is host-derived.
MMP-2 Associated with avb3 on CS-1 Cells
Is Functionally Active
To establish whether the MMP-2 associated with these
tumors was in a functionally active form, lysates were
prepared from b3CS-1, b5CS-1, or control CS-1 tumors.
These lysates were then analyzed for MMP-2 activity by
gelatin zymography. MMP-2 in the pro-enzyme form is
72 kDa; however, after proteolytic activation it appears
as 64/62 kDa species (Kleiner et al., 1993). As shown
in Figure 3A, gelatinolytic bands from avb3-expressing
tumor lysates were detected migrating at approximately
62 kDa. This activity was 3-fold higher than the gelatino- Figure 3. Increased Levels of Activated MMP-2 Associated with
lytic activity associated with avb5-expressing tumors avb3-Expressing CS-1 Tumors In Vivo
(b5CS-1) and 6-fold higher than control CS-1 tumors as Lysates prepared from CS-1 solid tumor variants grown on the CAM
determined by densitometry. These 62 kDa gelatinolytic of 10-day-old chick embryo were analyzed both by gelatin zymogra-
bands were confirmed to be MMP-2 by Western blot phy (A) and Western blotting using anti±MMP-2 as a primary anti-
body (B). Lane 1, control purified recombinant chick MMP-2. Laneanalysis (Figure 3B). In contrast, no significant changes
2, lysate (10 mg) from b3CS-1 tumors. Lane 3, lysate (10 mg) fromwere detected in uPA levels among these same tumors
control CS-1 tumors. Lane 4, lysate (10 mg) from b5CS-1 tumors.(data not shown). Thus, CS-1 tumors expressing integrin
avb3 had significantly enhanced levels of proteolytically
expressing avb3 were allowed to incubate with eitheractive MMP-2 compared with tumors expressing inte-
wild type (MMP-2 wild type) or a truncation mutant ofgrin avb5 or controls.
MMP-2 (DMMP-2(1±445)) lacking residues 446±631. ThisThese findings raise the possibility that avb3 ligation
truncated form of MMP-2 retains a functional catalyticon CS-1 cells leads to the induction of MMP-2 expres-
domain with gelatinolytic activity equal to that of thesion in these tumors, which may account for the in-
wild-type enzyme (data not shown). Bindingof MMP-2 tocreased MMP-2 activity observed. However, ligation of
avb3 was monitored by an anti-b3 monoclonal antibodyavb3 does not appear to promote expression of gela-
(MAb) directed to the ligand occupied form of avb3,tinolytic activity in b3CS-1 cells, since attachment of
termed Ligand-Induced Binding Site 1 (LIBS-1). This an-these cells to vitronectin, fibronectin, or collagen failed
tibody detects the ligand-occupied forms of both aIIbb3to increase gelatinolytic activity compared with non-
on platelets (Frelinger et al., 1990) and avb3 on mela-attached cells (data not shown). These findings provide
noma cells (Filardo et al., 1995). As shown in Figure 4,further evidence that the MMP-2 observed within these
MMP-2 (wild type) but not DMMP-2(1±445) promotedtumors is likely derived from host tissues.
LIBS-1 binding activity, as measured by flow cytometric
analysis. This LIBS-1 binding was similar to that ob-
servedwhen avb3 was occupiedwith soluble vitronectin
Interaction of Soluble MMP-2 with Integrin or cyclic RGDfV peptide (Figure 4). These findings sug-
avb3 on the Cell Surface gest that soluble MMP-2 can interact with integrin avb3
To establish whether soluble MMP-2 can specifically expressed on the cell surface and that this interaction
depends on the presence of its C-terminus.bind avb3 expressed on the cell surface, CS-1 cells
Cell Invasion Integrin avb3 and Matrix Metalloproteinase
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Figure 4. Soluble MMP-2 Binds Integrin avb3 Expressed on b3CS-1 Melanoma Cells
Subconfluent CS-1 melanoma cells expressing integrin b3 (b3CS-1) were harvested with versene and washed with sterile PBS. b3CS-1 cells
were incubated with various ligands, including BSA, vitronectin, control cyclic peptide 69601 (RADfV), cyclic peptide 66203 (RGDfV), wild-
type recombinant MMP-2, or C-terminal truncated MMP-2 (DMMP-2(1±445)). Cells were next incubated with MAb LIBS-1, an antibody that
specifically recognizes the ligand-occupied form of b3 integrins. Binding of integrin avb3 was quantified by measuring MAb LIBS-1 binding
by fluorescence-activated cell sorting. Fluorescence intensity is indicated in arbitrary units. Experiments were performed two to three times.
Soluble MMP-2 Selectively Prevents Adhesion
of avb3-Bearing CS-1 Cells to Vitronectin
To explore further the interaction between MMP-2 and
cell-surface avb3, b3CS-1 cells were allowed to attach
to vitronectin or laminin in the presence of excess solu-
ble MMP-2 (wild type) or DMMP-2(1±445). As shown in
Figure 5, soluble MMP-2 blocked cell adhesion to
vitronectin but had no effect on adhesion to laminin.
Similar results were obtained with a cyclic peptide an-
tagonist of avb3 (RGDfV), which selectively blocked ad-
hesion to vitronectin while a control cyclic peptide
(RADfV) had no effect. We then examined the effects of
DMMP-2(1±445). Once again, this truncation mutant did not
appear to interact with avb3, since it was unable to
block vitronectin-mediated attachment of these cells.
These findings support the notion that avb3-expressing
CS-1 cells can interact with MMP-2 in a manner that
depends on a region within the C-terminal 181 amino
acid residues of MMP-2.
MMP-2 Binds Specifically to Purified Integrin
avb3 Forming an SDS-Stable Complex
To establish whether MMP-2 could directly bind avb3,
we first examined the ability of recombinant MMP-2 to
interact with purified avb3 in a solid-phase binding
assay. Integrins avb3, avb5, or the fibronectin receptor
a5b1 were coated onto microtiter wells and allowed to
interact with either MMP-2, vitronectin, fibronectin, or
collagen, as previously described (Orlando and Cher-
Figure 5. Effect of Soluble MMP-2 on b3CS-1 Melanoma Cell Adhe-
esh, 1991). As shown in Figure 6A, MMP-2 readily bound sion to Vitronectin and Laminin
avb3 but had only a minimal interaction with avb5
b3CS-1 melanoma cells were pretreated for 30 min with either con-
(35% of that detected with avb3) and failed to interact trol cyclic peptide 69601 (RADfV), cyclic peptide 66203 (RGDfV),
with a5b1. As expected, vitronectin bound to both avb3 wild-type recombinant chick MMP-2, or C-terminal truncated
MMP-2 (DMMP-2(1±445)). Cells were resuspended in adhesion bufferand avb5, while fibronectin interacted with both avb3
and allowed to attach to microtiter wells coated with either vitronec-and a5b1 but not avb5. Importantly, both vitronectin and
tin or laminin.MMP-2 bound to avb3 in a dose-dependent and satura-
(Top) Shaded bars indicate mean plus standard deviation ofble manner, whereas collagen failed to bind avb3 at all
b3CS-1 cell adhesion to vitronectin.
concentrations tested (Figure 6B). This interaction was (Bottom) Hatched bars indicate mean plus standard deviation of
blocked with cyclic peptide 203 (RGDfV) but not the b3CS-1 cell adhesion to laminin.
Experiments were performed two to three times with triplicate wells.control cyclic peptide 601 (RADfV) (data not shown).
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These findings demonstrate that MMP-2 specifically
binds integrin avb3 while having a minimal interaction
with avb5 and showing no binding to the fibronectin
receptor, a5b1.
To examine further the interaction between integrin
avb3 and MMP-2, these proteins were allowed to inter-
act in solution and were separated by SDS±poly-
acrylamide gel electrophoresis (SDS±PAGE) without
boiling. As shown in Figure 6C, addition of MMP-2 to
purified avb3 resulted in the formation of SDS-stable
complexes, as demonstrated by the presence of slowly
migrating broad bands (approximately 200 kDa and 150
kDa) and the concomitant dose-dependent decrease of
the av and b3 integrin subunits. In contrast, no complex
formation was detected between MMP-2 and a5b1. In
addition, the truncation mutant also failed to form a
complex with avb3 (Figure 6C). Boiling these samples
prior to their separation by SDS±PAGE resulted in the
dissociation of the complexes such that the av and b3
subunits migrated in their normal positions of 145 kDa
and 95 kDa, respectively (data not shown). To establish
that the shifted bands contained either av or b3 integrin
subunits, we analyzed these same samples by Western
blot with antibodies directed either to av or b3 (Figure
6D). As shown in Figure 6D (left panel), anti-b3 antibody
readily detects the b3 subunit of purified avb3 as well
as the lower of the two shifted bands, with an apparent
molecular mass of approximately 150 kDa. Likewise,
anti-av antibody recognized both the av subunit from
purified avb3 and the broad shifted band migrating at
approximately 200 kDa. Taken together, these data
demonstrate that the full-length MMP-2 is capable of
forming an SDS-stable complex with integrin avb3, pro-
viding further evidence that these proteins physically
interact.
MMP-2 on the Surface of avb3-Expressing
Cells Is Functionally Active
To determine whether the MMP-2 localized on the sur-
face of avb3-expressing CS-1 cells was functionally ac-
tive, we incubated CS-1 cells expressing avb3, avb5,
or control CS-1 cells with MMP-2 and then added to
Figure 6. Soluble MMP-2 Specifically Binds Purified Integrin avb3
(A) Purified integrin receptors (1 mg/ml), avb3, avb5, and a5b1 were
coated on wells of a 96-well microtiter plate. Integrin ligands, includ-
ing vitronectin, collagen, and fibronectin or purified recombinant
MMP-2 (5 ng), were incubated in wells coated with integrin recep-
tors. Specific protein binding was quantified by measuring reactivity
of ligand-specific antibodies. Data bars represent the mean plus or
minus standard errors of ligand binding from three to five experi-
ments with triplicate wells.
(B) Microtiter plates were coated with purified integrin avb3. Integrin
ligands, including vitronectin and collagen or recombinant MMP-2,
at concentrations ranging from 5 ng/ml±500 ng/ml, were allowed to
bind to integrin-coated wells. Dose response binding was quantified
as described above.
(C) Purified integrins avb3 and a5b1 were incubated with soluble
wild-type MMP-2 (wt) (5 ng±40 ng/lane) or C-terminal mutant MMP-
2(1±445) (20 ng/lane) for 4 hr at 378C in a total volume of 100 ml. Samples
were analyzedby silver stain ona 6% SDS±PAGE gel without boiling.
(D) Purified avb3 or avb3 incubated with MMP-2 as described above
were analyzed by Western blotting with antibodies directed either
to the b3 integrin subunit (left panel) or the av integrin subunit (right
panel).
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689
and Zetter, 1990; Albelda, 1993). This process depends
both on adhesion and migration and on proteolytic
mechanisms that function in a coordinated manner to
provide directional cell migration (Albelda, 1993; Blasi,
1993; Mignatti and Rifkin, 1993). Thus, adhesion recep-
tors that potentiate cell invasion must function in the
context of specific proteases that serve to modify com-
ponents within the extracellular matrix. To this end, evi-
dence is provided that integrin avb3 not only promotes
cell migration on a wide range of matrix proteins (Feld-
ing±Habermann and Cheresh, 1993) but also serves as
a receptor for MMP-2 on the cell surface, facilitating its
expression in a functionally active form. These findings
provide unique evidence for a single cell-surface recep-
tor capable of regulating both cell movement and pro-
teolytic degradation of matrix.
Several lines of evidence suggest that integrin avb3
binds MMP-2 and acts as a receptor for surface-local-
ized metalloproteinase activity. First, avb3 and MMP-2
were colocalized on the surface of invasive angiogenic
vascular cells and melanoma cells in vivo. Second, ex-
pression of avb3 on cultured CS-1 melanoma cells
enabled them to bind soluble recombinant MMP-2, fa-
cilitating collagen degradation. In addition, MMP-2 in-
hibited b3CS-1 cell attachment to vitronectin. However,
these cells could attach and spread on immobilized type
IV collagen in the presence of active cell surface±
associated MMP-2 (data not shown). These findingsFigure 7. Cell Surface±Associated MMP-2 Promotes Type IV Colla-
suggest that avb3 can simultaneously bind both MMP-2gen Degradation
and proteolyzed collagen fragments. Finally, a direct(A) Control CS-1 cells or CS-1 cells expressing integrin avb3
interaction between avb3 and MMP-2 was demon-(b3CS-1) or avb5 (b5CS-1) were incubated with or without purified
recombinant MMP-2, and nonbound enzyme was washed free. CS- strated between these proteins in vitro. In fact, they
1 cell variants were incubated for 24 hr in wells of a microtiter plate formed an SDS-stable complex that depended on the
coated with 3H-labeled type IV collagen. Net collagen degradation C-terminus of MMP-2. The specificity of this interaction
from each cell variant was quantified by subtracting the cpm re- was demonstrated since MMP-2 bound poorly to avb5
leased from 50 ml of medium, from cells pretreated in the absence
(35% of that observed bound to avb3) and not to theof added enzyme, from cells pretreated with MMP-2.
fibronectin receptor a5b1, even though each of these(B) b3CS-1 cells pretreated with either wild type MMP-2 (open bars)
or C-terminal truncated MMP-2 (closed bars). Data bars represent receptors binds to their ligands in an Arginine±glycine±
mean plus standard error of net cpm released. Experiments were aspartic acid (RGD) dependent manner. It is of interest
performed two to four times with triplicate wells. that MMP-2 does not contain an RGD sequence and,
thus, it is not clear how avb3 interacts with MMP-2.
However, removal of 181 residues from the C-terminus
microtiter wells coated with 3H-labeled type IV collagen. abolishes this binding event, suggesting that the C-ter-
MMP-2 activity was monitored by collagen IV degrada- minus of MMP-2 is required for this interaction. These
tion, as measured by release of cpm into the medium. findings are consistent with a role for the C-terminus of
As shown in Figure 7A, only avb3-expressing CS-1 cells MMP-2 in its localization to the cell surface (Strongin et
caused a significant increase in collagen degradation, al., 1995; Cao et al., 1995). Moreover, this truncated form
as compared with either control or avb5-expressing of MMP-2 still retains its catalytic activity, suggesting
CS-1 cells. In contrast, when avb3-bearing CS-1 cells that cell-surface binding and enzymatic activities are
were preincubated with the C-terminal truncated form represented by distinct domains of this enzyme.
of MMP-2, which retains its collagenolytic activity, no Our findings are consistent with previous reports
significant increase in type IV collagen degradation was showing that MMP-2 as well as integrin receptors local-
detected (Figure 7B).This cell-surface collagenolytic ac- ize tothe invadopodia of Roussarcoma virus±transformed
tivity was sensitive to the metalloproteinase inhibitor chick embryo fibroblast (Monsky et al., 1993; Mueller
1±10 phenanthroline and was insensitive to the serine and Chen, 1991). Interestingly, this localization was de-
proteinase inhibitor aprotinin (data not shown), sug- pendent on the presence of Ca21 and Mg21 (Monsky et
gesting that the MMP-2 added to these cells, which al., 1993), which are also critical for integrin function.
bound to avb3, was responsible for the observed colla- To date, little is known regarding the biochemical inter-
gen degradation. actions between MMPs and the cell surface. However,
a transmembrane form of MMP was recently identified
Discussion called MT-MMP (Sato et al., 1994). This novel metallo-
proteinase, in conjunction with tissue inhibitor of metal-
Directed cell motility in tissues is critical during develop- loproteinase-2 (TIMP-2), has been implicated in localiza-
tion and activation of MMP-2 on the cell surfacement, wound repair, inflammation, and cancer (Blood
Cell
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Experimental Procedures(Strongin et al., 1995). However, it is not clear how this
trimolecular interaction might potentiate the migration
Antibodies and Reagentsof cells in vivo. In addition, the serine proteinase uPA
MAb LIBS-1, which reacts preferentially with the ligand-occupiedbinds to its receptor, termed uPAR, which associates
form of b3 integrins (Frelinger et al., 1990) was provided by Dr.with the outer leaflet of the bilayer (Blasi, 1993). This
M. Ginsberg (Scripps Research Institute, La Jolla, CA). MAb anduPA enzymatic activity appears to potentiate tumor cell
polyclonal antisera to human progelatinase A (MMP-2) was recently
invasive behavior (Crowley et al., 1993; Kook et al., described (Brown et al., 1990). Polyclonal antibody to fibronectin
1994). In fact, recent evidence suggests that proteases was obtained from Chemicon (Temecula, CA). MAb LM609, anti-
and their receptors may be functionally associated with avb3, and polyclonal antibodies 661 to vitronectin have been de-
scribed previously (Gladson and Cheresh, 1991; Wayner et al., 1991).integrin receptors. For example, it has been shown that
MAb AP3 (Newman et al., 1985) was provided by Dr. P. NewmanuPAR colocalizes with integrin avb5 on migratory cells
(Milwaukee Blood Center, Milwaukee, WI). Polyclonal antibodies to(Reinartz et al., 1995). However, no biochemical evi-
type I collagen and av integrin subunit were obtained from Chemi-dence exists suggesting that these receptors are struc-
con. Rhodamine-conjugated goat anti-mouse IgG and FITC conju-
turally linked on the cell surface. A novel family of mole- gated goat anti-rabbit IgG were obtained from Bio Source Interna-
cules designated ADAMS has been identified that tional (Camarillo, CA). Purified integrin a5b1 was a gift from Dr. S.
contains both integrin binding sequences and a metallo- Argraves (American RedCross, Washington, DC). Integrins avb3 and
avb5 were purified from placental tissues as previously describedproteinase catalytic domain (Wolfsberg et al., 1993,
(Smith et al., 1990; Smith and Cheresh, 1988). Recombinant chick1995), suggesting the possibility of integrin-mediated
MMP-2 and C-terminal truncation mutant DMMP-2(1±445) was con-cell-surface localization of metalloproteinase activity.
structed as previously described (Aimes et al., 1994). 3H-labeled
The finding that avb3 binds MMP-2 on the cell surface type IV collagen (1.075 mCi/mg) was obtained from Dupont NEM
suggests that this interaction may contribute to cellular (Boston, MA). Purified laminin and fibronectin were obtained from
invasion in vivo. In support of this contention is the Sigma (St. Louis, MO). Collagen type I was obtained from UBI (Lake
observation that avb3 and MMP-2 were colocalized on Placid, NY). Cyclic peptides 66203 (cyclo-RGDfV) directed to avb3
and avb5 and control peptide 69601 (cyclo-RADfV) (Pfaff et al., 1994;the surface of both angiogenic vascular cells and inva-
Friedlander et al., 1995) with A denoting b-alanine were synthesizedsive melanoma cells within tumor tissue. Interestingly,
and characterized by Drs. A. Jonczyk, B. Diefenbach, and S. Good-while avb3 fails to bind native collagen, it does interact
man (Merck KGaA, Darmstadt, Federal Republic of Germany).
with proteolyzed collagen owing to exposure of a cryptic
RGD site (Davis, 1992; Montgomery et al., 1994), sug-
Cell Lines and Solid Tumorsgesting that avb3 on the surface of invasive cells can
CS-1 hamster melanoma cells lacking expression of avb3 and avb5both regulate collagen degradation and interact with the
were provided by Dr. C. Damsky (University of California, San Fran-
resulting fragments. In fact, this is supported by the cisco, CA) (Knudsen et al., 1982; Thomas et al., 1993). CS-1 cells
observation that avb3 antagonists (Brooks et al., 1994b, were transfected with either b3 (b3CS-1) or b5 (b5CS-1) integrin
1995), as well as tissue inhibitors of metalloproteinases, subunits as described previously (Filardo et al., 1995, 1996). CS-1
tumor cell variants were maintained in RPMI 1640 with 5% fetalblock angiogenesis in vivo (Moses et al., 1990). Thus, it
bovine serum supplemented with 50 mg/ml gentamicin. Solid mela-is possible that avb3 and MMP-2 functionally cooperate
noma tumors were produced by inoculating the CAMs of 10-day-to promote the invasive behavior of angiogenic vascular
old chick embryos with 5 3 106 CS-1, b3CS-1, or b5CS-1 tumor
cells. Likewise, highly invasive melanoma cells typically cells, as previously described (Brooks et al., 1993; Filardo et al.,
invade vertically into the dermis, which is rich in collagen 1995). The tumors were allowed to develop for 7 days, then trimmed
(Albelda et al.,1990). In fact, we observed that melanoma free of surrounding CAM tissue and minced for lysate preparation.
cells expressing avb3 were highly invasive in vivo com- For analysis of angiogenic blood vessels, the CAMs of 10-day-
old chick embryo were treated with or without basic fibroblastpared with cells lacking this integrin (Filardo et al., 1995).
growth factor as previously described (Brooks et al., 1994a). TheIt is conceivable that this difference in invasive behavior
CAMs were resected, washed in phosphate-buffered saline (PBS),in vivo is due in part to the ability of avb3 to bind to
embedded in OCT medium (Baxter, McGraw Park, IL), and snap-
MMP-2. The relative increase in MMP-2 associated with frozen in liquid nitrogen for preparation of cryostat sections. Human
avb3-bearing CS-1 tumors appears to be derived from tumor-associated blood vessels were analyzed from avb3-negative
host (chick) tissue, since MMP-2 was only detected on human melanoma tumors (M21-L) grown in human skin transplanted
the cell surface (Figure 2) while avb3 was detected both on severe combined immunodeficient mice, as previously described
(Yan et al., 1993; Brooks et al., 1995).on thesurface and within thecytoplasm of b3CS-1 tumor
cells. In addition, CS-1 cells produce little if any gelatino-
lytic activity in vitro (Thomas et al., 1993), and attach- Gelatin Zymography and Western Blot Analysis
Cultured CS-1 tumor cells or fragments of solid CS-1 tumors grownment of avb3-expressing CS-1 cells to vitronectin does
in vivowere finely minced and resuspended in lysis buffer containingnot increase MMP-2 expression, suggesting that ligation
1% triton X-100, 50 mM Tris, 300 mM NaCl. Lysates were incubatedof this receptor does not influence MMP-2 levels in these
on ice for 15 min with occasional vortexing, and insoluble material
tumor cells. Together, these results suggest that the was removed by centrifugation. Gelatin zymography was performed
MMP-2 found to be associated with avb3-bearing as previously described (Nakajima et al., 1995). Briefly, 10±20 mg
CS-1 cells is derived from the host tissues. of total protein from lysates were electrophoresed through a 10%
The findings presented in this report demonstrate a SDS±PAGE gel polymerized with 0.2% gelatin. Gels were washed
three times for 1 hr each in 2.5% triton X-100 to remove SDS.novel interaction between an integrin and a protease on
Gels were next incubated for 16 hr at 378C in collagenase bufferthe surface of invasive cells. The fact that avb3promotes
containing 50 mM Tris±HCL, 200 mM NaCl, and 10 mM CaCl2 (pHcell motility while MMP-2 potentiates matrix degradation
7.5). Gelatinolytic activity was visualized by staining the gels with
suggests that these proteins function in a cooperative 0.5% Coomassie blue. To detect plasminogen activators, plasmino-
manner to promote the invasive behavior of cells during gen (1.2 mg/ml) was copolymerized with the gels and collagenase
tissue remodeling, inflammation, development, and inhibitors EDTA (20 mM), and 1±10 phenathroline (1 mM) was added
to the gel incubation buffer. For Western blot analysis, 10 mg ofcancer.
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tumor lysates or equal volumes of avb3/MMP-2 complex were elec- for 30 min at 378C. CS-1 tumor cells (1 3 105) resuspended in adhe-
sion buffer, fibroblast basal medium containing 0.5% BSA, and 0.2trophoresed on a 6% SDS±PAGE gel under nonreducing conditions.
Proteins were transferred to nitrocellulose membranes and probed mM MnCl2 were allowed to attach for 15 min. Plates were washed
with adhesion buffer to remove nonattached cells, and attachedwith polyclonal anti±MMP-2 antibodies (1:1000), anti-av antibodies
(1:500), or MAb AP3 (anti-b3) (5 mg/ml), followed by incubation with cells were stained with 1% crystal violet. Cell-associated crystal
violet was eluted by the addition of 100 ml of 10% acetic acid. Cellperoxidase-labeled secondary antibodies. Western blots were visu-
alized by enhanced chemiluminescence detection system ac- adhesion was quantified by measuring the optical density of the
eluted crystal violet at a wavelength of 600 nm.cording to the manufacturer's instructions. MMP-2 activity was
quantified by densitometric scanning of zymographic bands.
Flow Cytometry
Immunofluoresence Analysis of CS-1 Melanoma Tumors Fluorescence-activated cell sorting was performed as previously
Immunofluorescent staining was performed as previously de- described (Brooks et al., 1994b). Briefly, subconfluent b3CS-1 cells
scribed, with minor modifications (Brooks et al., 1995). Micron cryo- were harvested with versene and washed three times with serum-
stat sections (4) of b3CS-1, b5CS-1, and control CS-1 tumors were free RPMI 1640. Cells were incubatedfor 30 min with peptides69601
incubated with 1% bovine serum albumin (BSA) in PBS for 1 hr at (RADfV), 66203 (RGDfV) (100 mM), vitronectin, BSA (100 mM),
room temperature, followed by incubation with polyclonal anti± MMP-2, or DMMP-2(1±445) (4 nM). Cells were incubated with MAb
MMP-2 antisera at a dilution of 1:250 in 1% BSA in PBS for 2 hr. LIBS-1 (15 mg/ml) in 0.5% BSA in fibroblast basal medium supple-
Tissue sections were washed five times with PBS for 5 min, followed mented with 0.2 mM MnCl2, washed two times and incubated with
by incubation with FITC conjugated goat anti-rabbit IgG. Tissue phycoerythrin-labeled goat anti-mouse IgG at a dilution of 1:50. The
sections were washed as described above and mounted with fluoro- cells were then analyzed by fluorescence-activated cell sorting. Cell
mount G (Southern Biotechnology Associates, Birmingham, AL). For fluorescence was measured with a FACScan flow cytometer (Bec-
double-staining analysis, anti-avb3 MAb LM609 (30mg/ml) and poly- ton±Dickinson, Mountain View, CA). The data were collected with a
clonal anti±MMP-2 (1:250) were incubated together for 2 hr at room Hewlett±Packard (HP9000) computer equipped with FACScan re-
temperature. After washing, tissue sections were incubated with search software. The data was analyzed with PC Lysis software.
both rhodamine-conjugated goat anti-mouse IgG and FITC conju- Population gates were set using cells incubated without primary
gated goat anti-rabbit IgG at a dilution of 1:250 in 1% BSA in PBS. antibody. LIBS-1 binding was corrected by subtracting binding from
cells in the absence of ligand.
Solid-Phase Binding Assay
Purified receptor binding assays were performed essentially as de- 3H-Labeled Type IV Collagen Degradation Assay
scribed, with minor modifications (Orlando and Cheresh, 1991). Cluster plates (96-well) were coated with 50 ml of 3H-labeled type
Briefly, enzyme-linked immunoabsorbent assay plates were coated IV collagen solution (500±1000 cpm/mg protein) and allowed to dry
(100 ml) with 1.0 mg/ml of purified integrins avb3, avb5, or a5b1 in overnight in a laminar flow hood at room temperature. Plates were
binding buffer containing 20 mM Tris, 150 mM NaCl, and 1 mM washed extensively with PBS until free cpm reached basal levels.
CaCl2, MgCl2, and MnCl2 (pH 7.4) for 16 hr at 48C. The plates were CS-1 tumor cells were incubated for 2 hr in the presence or absence
washed three times with 200 ml/well of sterile PBS. Plates were then of purified MMP-2 or C-terminal±truncated MMP-2 (200 ng/ml) in a
incubated (100 ml) with 0.5% protease-free BSA in PBS for 1 hr at total volume of 500 ml of fibroblast basal medium containing 2.5%
378C and then washed six times with sterile PBS (200 ml/well). Puri- BSA, 0.2 mM MnCl2 and 10 mg/ml aprotinin. In control experiments,
fied ligands including vitronectin, collagen type I, fibronectin, and 1 mM 1±10 phenanthroline was added to the buffer. CS-1 tumor
MMP-2 (0.5±50 ng/well) in a total volume of 100 ml were incubated cells (1 3 105) in a total volume of 200 ml were allowed to incubate
for 1 hr at 378C. Plates were washed as before, followed by incuba- for 24 hr at 378C. Collagen degradation was accessed by measuring
tion with anti-ligand specific polyclonal antisera at a dilution ranging the cpm released in 50 ml of medium. Net collagen IV degradation
from 1:1000 to 1:5000 in 0.5% BSA in PBS for 1 hr at 378C. The was determined by subtracting cpm released in the absence of
enzyme-linked immunoabsorbent assay plates were washed as be- added MMP-2.
fore and incubated with peroxidase-conjugated goat anti-rabbit IgG
at a dilution of 1:3000 in 0.5% BSA in PBS. Finally, plates were
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